Acurox®

  Commercial Agreements
 
  
 
Home
PR 01/02/2009
PR 12/24/2008
PR 10/27/2008
PR 10/13/2008
PR 10/10/2008
PR 09/02/2008
PR 07/30/2008
PR 07/21/2008
PR 06/30/2008(1)
PR 06/30/2008(2)
PR 06/17/2008
PR 06/03/2008
PR 06/02/2008
PR 05/27/2008
PR 04/30/2008
PR 04/24/2008
PR 03/24/2008
PR 03/05/2008
PR 02/27/2008
PR 01/31/2008
PR 01/24/2008
PR 12/10/2007
PR 12/04/2007
PR 11/02/2007
PR 10/31/2007 (1)
 
PR 10/10/2008

 

                  

Text Box: Acura Pharmaceuticals Contact:             Peter A. Clemens, SVP Investor Relations & CFO  847-705-7709

ACURA PHARMACEUTICALS, INC. TO PRESENT

AT NATIXIS BLEICHROEDER HIDDEN GEMS CONFERENCE

Palatine, IL October 10, 2008: Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) announced  that Robert Jones, Chief Operating Officer, will present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th at 3:00 p.m. ET at the Waldorf Astoria in New York City. A live audio webcast of the presentation will be available at http://www.wsw.com/webcast/nblr2/acur/.  A replay of the webcast may be accessed for 30 days at the same website. 

About Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion® (abuse deterrent) Technology and related product candidates.  For more information, please visit www.acurapharm.com.

 

Any questions or comments regarding Press Releases should be directed to our department of Investor Relations.

Return to the Press Release Archive

 
 
 

 
Home   Sitemap
Copyright © 1998-2008 Acura Pharmaceuticals.  All rights reserved.